Frontiers | A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs | Pharmacology
Frontiers | A Review of Treatment of Coronavirus Disease 2019 (COVID-19): Therapeutic Repurposing and Unmet Clinical Needs | Pharmacology
The complexities of antiretroviral drug–drug interactions: role of ABC and SLC transporters: Trends in Pharmacological Sciences
Drug Discovery Strategies for SARS-CoV-2 | Journal of Pharmacology and Experimental Therapeutics
Viren Kaul, MD on Twitter: "Cao: Drug targets for Rx of #COVID19 - prevent Endo some mediated viral entry: Chloroquine - inhibit RNA synthesis: Remdesivir - IL-6 anatagonists to prevent downstream cytokine
Atazanavir Pathway, Pharmacokinetics/Pharmacodynamics
A comparative analysis of remdesivir and other repurposed antivirals against SARS‐CoV‐2 | EMBO Molecular Medicine
HIV protease inhibitors and onset of cardiovascular diseases: A central role for oxidative stress and dysregulation of the ubiquitin–proteasome system - ScienceDirect
Research Highlight: Derivatization and Combination Therapy of COVID-19 Therapeutic agents | LAU News
Core Concepts - Antiretroviral Medications and Initial Therapy - Antiretroviral Therapy - National HIV Curriculum
HIV Protease Inhibitor Ritonavir Impairs Endothelial Function Via Reduction in Adipose Mass and Endothelial Leptin Receptor‐Dependent Increases in NADPH Oxidase 1 (Nox1), C‐C Chemokine Receptor Type 5 (CCR5), and Inflammation | Journal
Therapeutics for COVID-19: from computation to practices—where we are, where we are heading to | SpringerLink
Experimental COVID-19 Therapy Combination Lopinavir/Ritonavir Is Implicated in a Complicated Set of Drug-Drug Interactions - Anesthesia Patient Safety Foundation
Paxlovid- history and mechanism of action - Santiago lab
Repurposed Antiviral Drugs for the Treatment of COVID-19: Syntheses, Mechanism of Infection and Clinical Trials | Bentham Science
Figure. Antimyeloma mechanism of action of nelfinavir. Nelfinavir... | Download Scientific Diagram
Guidance on Short‐Term Management of Atrial Fibrillation in Coronavirus Disease 2019 | Journal of the American Heart Association
Emerging pharmacotherapies for COVID-19 - ScienceDirect
Avraham Z. Cooper, MD on Twitter: "4/ Third, lopinavir/ritonavir 🔹Lopinavir 🚫viral proteases, blocking formation of viral proteins (step 3 in diagram below) and interrupting replication 🔹Ritonavir is a Cytochrome-P3A inhibitor, preventing metabolism
IJMS | Free Full-Text | Existing Drugs Considered as Promising in COVID-19 Therapy | HTML
Schematic representation of ritonavir's action. Abbreviations: CYP3A4,... | Download Scientific Diagram
Antibiotics | Free Full-Text | Oral Nirmatrelvir/Ritonavir Therapy for COVID-19: The Dawn in the Dark? | HTML
Lopinavir - an overview | ScienceDirect Topics
Life | Free Full-Text | Statins in COVID-19 Therapy | HTML
